Modulo Bio

Modulo Bio

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://modulo.bio

Last Round

Early Funding

Mar 19, 2025

Total Funding Raised

$19.15M

Momentum Score

25 /100

Company Overview

Modulo Bio is a biotechnology company that develops treatments for neurodegenerative disorders by reprogramming the brain's immune system.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Application

Keywords

AI drug discoveryneurodegenerative diseasedrug discovery platformneuroimmunologymicroglia reprogrammingAI biotechpatient-derived stem cellsiPSC modelsmulti-omicsdrug target identificationneuroprotective therapeuticspreclinical biotechnologybiopharma partnershipsALSFTD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Modulo Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Modulo Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 19, 2025
GrantFeb 7, 2025
SeedDec 5, 2024
SeedJun 1, 2023

Key People

Founding team and executive leadership

Scott Patterson

Co-Founder CTO

Founding Team

Modulo Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2025

    $4.8M raised in early funding.

  • Feb 7, 2025

    $500K raised in a Grant round.

Modulo Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Modulo Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Modulo Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range13
Year Founded2021
Last FundingMar 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.